Skip to main content
. 2018 Aug 24;9(66):32624–32641. doi: 10.18632/oncotarget.25976

Figure 8. Classification analysis of 6 RPPA-measured proteins in 210 serum samples (132 HCC patients and 78 healthy controls) to evaluate their diagnostic performance as biomarkers of HCC.

Figure 8

Figure 8

Figure 8

(A) The individual ROC curve for each biomarker. (B) Hierarchic clustering of HCC and healthy samples based on expression level changes of all 6 biomarkers. (C) Evaluation of diagnostic performance of all 6 biomarkers against HCC patients (red) and healthy controls (blue) with PCA analysis. (D) AUC rate of the combined 6 biomarkers (B2M, IGFBP2, GP73, GDF15, OPN and AFP) as a specific HCC signature evaluated by supervised LR, LDA, RF and SVM models in a training set and a validation set as described in the Methods section.